...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: TNBC no longer active?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"FDA will no longer accept a phase 2 as registration enabling."

Can't see the FDA standing in the way of a free market economy.

jonzobot: I asked Chris (IR) to expand on Don's comment (made at the AGM) about why Zenith is no longer pursuing TNBC with ZEN-3694 because someone got there first. 

 

Koo 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply